deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL 2-arm NCT02726490

Glyburide vs Glucovance in the Treatment of GDM (GGIG)

Glyburide vs Glucovance in the Treatment of Gestational Diabetes

Sponsor: Texas Tech University Health Sciences Center, El Paso

Updated 7 times since 2017 Last updated: Oct 7, 2020 Started: Jul 31, 2016 Primary completion: Aug 14, 2018 Completion: Aug 14, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of Recruitment

This EARLY_PHASE1 trial investigates Gestational Diabetes and is currently terminated or withdrawn. Texas Tech University Health Sciences Center, El Paso leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotRecruiting~Dec 2018 – ~Nov 2020 · 23 months · monthly snapshotTerminated~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated EARLY_PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated EARLY_PHASE1

  4. Nov 2020 — Jan 2021 [monthly]

    Terminated EARLY_PHASE1

    Phase: NAEARLY_PHASE1

  5. Dec 2018 — Nov 2020 [monthly]

    Terminated NA

    Status: RecruitingTerminated

Show 2 earlier versions
  1. Jun 2018 — Dec 2018 [monthly]

    Recruiting NA

  2. Jan 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Texas Tech University Health Sciences Center, El Paso
Data source: Texas Tech University Health Sciences Center, El Paso

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations